BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24548457)

  • 1. Presence of multiple binding sites on α9α10 nAChR receptors alludes to stoichiometric-dependent action of the α-conotoxin, Vc1.1.
    Indurthi DC; Pera E; Kim HL; Chu C; McLeod MD; McIntosh JM; Absalom NL; Chebib M
    Biochem Pharmacol; 2014 May; 89(1):131-40. PubMed ID: 24548457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of rat α9α10 nicotinic acetylcholine receptor with α-conotoxin RgIA and Vc1.1: Insights from docking, molecular dynamics and binding free energy contributions.
    Li R; Li X; Jiang J; Tian Y; Liu D; Zhangsun D; Fu Y; Wu Y; Luo S
    J Mol Graph Model; 2019 Nov; 92():55-64. PubMed ID: 31330438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Determinants Conferring the Stoichiometric-Dependent Activity of α-Conotoxins at the Human α9α10 Nicotinic Acetylcholine Receptor Subtype.
    Yu R; Tae HS; Tabassum N; Shi J; Jiang T; Adams DJ
    J Med Chem; 2018 May; 61(10):4628-4634. PubMed ID: 29733583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. αS-conotoxin GVIIIB potently and selectively blocks α9α10 nicotinic acetylcholine receptors.
    Christensen SB; Bandyopadhyay PK; Olivera BM; McIntosh JM
    Biochem Pharmacol; 2015 Aug; 96(4):349-56. PubMed ID: 26074268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic α-conotoxins Vc1.1 and RgIA inhibit N-type calcium channels in sensory neurons of α9 nicotinic receptor knockout mice.
    Callaghan B; Adams DJ
    Channels (Austin); 2010; 4(1):51-4. PubMed ID: 20368690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management?
    Mohammadi SA; Christie MJ
    Toxins (Basel); 2015 Sep; 7(10):3916-32. PubMed ID: 26426047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular interaction of α-conotoxin RgIA with the rat α9α10 nicotinic acetylcholine receptor.
    Azam L; Papakyriakou A; Zouridakis M; Giastas P; Tzartos SJ; McIntosh JM
    Mol Pharmacol; 2015 May; 87(5):855-64. PubMed ID: 25740413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor.
    Halai R; Clark RJ; Nevin ST; Jensen JE; Adams DJ; Craik DJ
    J Biol Chem; 2009 Jul; 284(30):20275-84. PubMed ID: 19447885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis for the differential sensitivity of rat and human α9α10 nAChRs to α-conotoxin RgIA.
    Azam L; McIntosh JM
    J Neurochem; 2012 Sep; 122(6):1137-44. PubMed ID: 22774872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Conotoxin Vc1.1 Structure-Activity Relationship at the Human α9α10 Nicotinic Acetylcholine Receptor Investigated by Minimal Side Chain Replacement.
    Chu X; Tae HS; Xu Q; Jiang T; Adams DJ; Yu R
    ACS Chem Neurosci; 2019 Oct; 10(10):4328-4336. PubMed ID: 31411453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α9α10 nicotinic acetylcholine receptors regulate murine bone marrow granulocyte functions.
    Safronova VG; Vulfius CA; Astashev ME; Tikhonova IV; Serov DA; Jirova EA; Pershina EV; Senko DA; Zhmak MN; Kasheverov IE; Tsetlin VI
    Immunobiology; 2021 Jan; 226(1):152047. PubMed ID: 33340828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of α9α10 Nicotinic Receptors With Peptides and Proteins From Animal Venoms.
    Tsetlin V; Haufe Y; Safronova V; Serov D; Shadamarshan P; Son L; Shelukhina I; Kudryavtsev D; Kryukova E; Kasheverov I; Nicke A; Utkin Y
    Front Cell Neurosci; 2021; 15():765541. PubMed ID: 35002625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal Structure of the Monomeric Extracellular Domain of α9 Nicotinic Receptor Subunit in Complex With α-Conotoxin RgIA: Molecular Dynamics Insights Into RgIA Binding to α9α10 Nicotinic Receptors.
    Zouridakis M; Papakyriakou A; Ivanov IA; Kasheverov IE; Tsetlin V; Tzartos S; Giastas P
    Front Pharmacol; 2019; 10():474. PubMed ID: 31118896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells.
    Elgoyhen AB; Vetter DE; Katz E; Rothlin CV; Heinemann SF; Boulter J
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3501-6. PubMed ID: 11248107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional expression of human α9* nicotinic acetylcholine receptors in X. laevis oocytes is dependent on the α9 subunit 5' UTR.
    Filchakova O; McIntosh JM
    PLoS One; 2013; 8(5):e64655. PubMed ID: 23717646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are alpha9alpha10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins?
    Nevin ST; Clark RJ; Klimis H; Christie MJ; Craik DJ; Adams DJ
    Mol Pharmacol; 2007 Dec; 72(6):1406-10. PubMed ID: 17804600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors.
    McIntosh JM; Plazas PV; Watkins M; Gomez-Casati ME; Olivera BM; Elgoyhen AB
    J Biol Chem; 2005 Aug; 280(34):30107-12. PubMed ID: 15983035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the α-conotoxin Vc1.1 binding site on the α9α10 nicotinic acetylcholine receptor.
    Yu R; Kompella SN; Adams DJ; Craik DJ; Kaas Q
    J Med Chem; 2013 May; 56(9):3557-67. PubMed ID: 23566299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-RgIA: a novel conotoxin that specifically and potently blocks the alpha9alpha10 nAChR.
    Ellison M; Haberlandt C; Gomez-Casati ME; Watkins M; Elgoyhen AB; McIntosh JM; Olivera BM
    Biochemistry; 2006 Feb; 45(5):1511-7. PubMed ID: 16445293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Contribution of Subunit Interfaces to α9α10 Nicotinic Acetylcholine Receptor Function.
    Boffi JC; Marcovich I; Gill-Thind JK; Corradi J; Collins T; Lipovsek MM; Moglie M; Plazas PV; Craig PO; Millar NS; Bouzat C; Elgoyhen AB
    Mol Pharmacol; 2017 Mar; 91(3):250-262. PubMed ID: 28069778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.